The Expression of Testin, Ki-67 and p16 in Cervical Cancer Diagnostics
Authors:
- Aneta Popiel-KopaczykAPAneta Popiel-Kopaczyk
- Jedrzej GrzegrzolkaJGJedrzej Grzegrzolka
- Aleksandra PiotrowskaAPAleksandra Piotrowska
- Mateusz OlbromskiMOMateusz Olbromski
- Beata SmolarzBSBeata Smolarz
- Hanna RomanowiczHRHanna Romanowicz
- Agnieszka RusakAgnieszka Rusak
- Monika MrozowskaMMMonika Mrozowska
- Piotr DziegielPDPiotr Dziegiel
- Marzenna Podhorska-OkolowMPMarzenna Podhorska-Okolow
- Christopher KobierzyckiCKChristopher Kobierzycki
Open Access
- 5 January 2023
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (1) , 490-500
Abstract
Testin is a protein expressed in normal human tissues, being responsible, with other cytoskeleton proteins, for the proper functioning of cell–cell junction areas and focal adhesion plaques. It takes part in the regulation of actin filament changes during cell spreading and motility. Loss of heterozygosity in the testin-encoding gene results in altered protein expression in many malignancies, as partly described for cervical cancer. The aim of our study was the assessment of the immunohistochemical (IHC) expression of testin in cervical cancer and its analysis in regard to clinical data as well the expression of the Ki-67 antigen and p16 protein. Moreover, testin expression was assessed by Western blot (WB) in commercially available cell lines. The IHC analysis disclosed that the expression of testin inversely correlated with p16 (r = −0.2104, p < 0.0465) and Ki-67 expression (r = −0.2359, p < 0.0278). Moreover, weaker testin expression was observed in cancer cases vs. control ones (p < 0.0113). The WB analysis of testin expression in the cervical cancer cell lines corresponded to the IHC results and showed a weaker expression compared to that in the control cell line. When we compared the expression of testin in cervical cancer cell lines, we found a weaker expression in HPV-negative cell lines. In summary, we found that the intensity of testin expression and the number of positive cells inversely correlated with the expression of Ki-67 (a marker of proliferation) and p16 (a marker of cell cycle dysregulation). This study shows that the combined assessment of testin, Ki-67 and p16 expression may improve cervical cancer diagnostics.Keywords
Funding Information
- Narodowe Centrum Nauki (2018/29/N/NZ5/01911)
This publication has 48 references indexed in Scilit:
- HPV: The global burdenNature, 2012
- Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemiaMolecular Cancer, 2010
- Epigenetics in cancerCarcinogenesis, 2009
- The LIM domain: from the cytoskeleton to the nucleusNature Reviews Molecular Cell Biology, 2004
- Focal Adhesion Protein Zyxin Is a Mechanosensitive Modulator of Gene Expression in Vascular Smooth Muscle CellsHypertension, 2004
- The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain proteinOncogene, 2001
- Characterization of the Human TESTIN Gene Localized in the FRA7G Region at 7q31.2Genomics, 2000
- Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomasOncogene, 1997
- 453 Loss of heterozygosity at 7Q31 is a frequent and early event in prostate cancerEuropean Journal of Cancer, 1995
- Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.Journal of Cell Biology, 1988